Sanara MedTech Inc

Sanara MedTech Inc. develops markets and distributes wound and skin care products to physicians hospitals clinics and post-acute care settings in the United States. It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel an antimicrobial hydrogel wound dressing helps against planktonic microbes as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds including pressure ulcers venous and arterial leg ulcers and diabetic foot ulcers. In addition it develops FORTIFY TRG a freeze-dried multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix an advanced wound care device; and VIM Amnion Matrix a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth Texas.